Tadalafil 5 mg tablets recall: CGMP Deviations
Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00
Why was Tadalafil 5 mg tablets recalled?
cGMP Deviations
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: B1635780-040522, Exp. Date 04/30/2023
- Product
- Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00
- Recalling firm
- RemedyRepack Inc.
- Quantity
- 16 bottles
- Distribution
- RemedyRepack distributed product to consignees nationwide within the United States
- Recall date
- April 12, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)